Skip to content

Efficacy and Safety of Red Ginseng on Decrement of Body Fat

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01734005
Enrollment
60
Registered
2012-11-27
Start date
2012-10-10
Completion date
2013-08-31
Last updated
2019-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

The investigators performed a 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of red ginseng on decrement of body fat. The investigators measured decrement of body fat parameters , including Body Fat Mass, Percent Body Fat, weight and BMI(body mass index), and monitored their blood pressure.

Interventions

DIETARY_SUPPLEMENTRed Ginseng

Red Ginseng (1.4g/day)

DIETARY_SUPPLEMENTPlacebo

Placebo (1.4g/day)

Sponsors

Chonbuk National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
19 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Males and females 19-65 years old * BMI(body mass index) ≥ 25 kg/m\^2 or WC(Waist Circumference) ≥ 90(men), WC ≥ 85(women) * Able to give informed consent

Exclusion criteria

* Significant variation in weight(more 10%) in the past 3 months * Allergic or hypersensitive to any of the ingredients in the test products * History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery * History of alcohol or substance abuse * Participation in any other clinical trials within past 2 months * Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study * Pregnant or lactating women etc.

Design outcomes

Primary

MeasureTime frameDescription
Changes in Body Fat Mass12 weeksBody Fat Mass was measured in study visit 1(0 week) and visit 3(12 week).
Changes in Percent Body Fat12 weeksPercent Body Fat was measured in study visit 1(0 week) and visit 3(12 week).

Secondary

MeasureTime frameDescription
Changes in weight12 weeksWeight was measured in study visit 1(0 week) and visit 3(12 week).
Changes in BMI(body mass index)12 weeksBMI(body mass index) was measured in study visit 1(0 week) and visit 3(12 week).

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026